Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

In English

Författare

  • Patrick J. Killela
  • Zachary J. Reitman
  • Yuchen Jiao
  • Chetan Bettegowda
  • Nishant Agrawal
  • Luis A. Diaz Jr.
  • Allan H. Friedman
  • Henry Friedman
  • Gary L. Gallia
  • Beppino C. Giovanella
  • Arthur P. Grollman
  • Tong-Chuan He
  • Yiping He
  • Ralph H. Hruban
  • George I. Jallo
  • Nils Mandahl
  • Alan K. Meeker
  • Fredrik Mertens
  • George J. Netto
  • B. Ahmed Rasheed
  • Gregory J. Riggins
  • Thomas A. Rosenquist
  • Mark Schiffman
  • Ie-Ming Shih
  • Dan Theodorescu
  • Michael S. Torbenson
  • Victor E. Velculescu
  • Tian-Li Wang
  • Nicolas Wentzensen
  • Laura D. Wood
  • Ming Zhang
  • Roger E. McLendon
  • Darell D. Bigner
  • Kenneth W. Kinzler
  • Bert Vogelstein
  • Nickolas Papadopoulos
  • Hai Yan
Visa allt

Summary, in English

Malignant cells, like all actively growing cells, must maintain their telomeres, but genetic mechanisms responsible for telomere maintenance in tumors have only recently been discovered. In particular, mutations of the telomere binding proteins alpha thalassemia/mental retardation syndrome X-linked (ATRX) or death-domain associated protein (DAXX) have been shown to underlie a telomere maintenance mechanism not involving telomerase (alternative lengthening of telomeres), and point mutations in the promoter of the telomerase reverse transcriptase (TERT) gene increase telomerase expression and have been shown to occur in melanomas and a small number of other tumors. To further define the tumor types in which this latter mechanism plays a role, we surveyed 1,230 tumors of 60 different types. We found that tumors could be divided into types with low (<15%) and high (>= 15%) frequencies of TERT promoter mutations. The nine TERT-high tumor types almost always originated in tissues with relatively low rates of self renewal, including melanomas, liposarcomas, hepatocellular carcinomas, urothelial carcinomas, squamous cell carcinomas of the tongue, medulloblastomas, and subtypes of gliomas (including 83% of primary glioblastoma, the most common brain tumor type). TERT and ATRX mutations were mutually exclusive, suggesting that these two genetic mechanisms confer equivalent selective growth advantages. In addition to their implications for understanding the relationship between telomeres and tumorigenesis, TERT mutations provide a biomarker that may be useful for the early detection of urinary tract and liver tumors and aid in the classification and prognostication of brain tumors.

Avdelning/ar

Publiceringsår

2013

Språk

Engelska

Sidor

6021-6026

Publikation/Tidskrift/Serie

Proceedings of the National Academy of Sciences

Volym

110

Issue

15

Dokumenttyp

Artikel i tidskrift

Förlag

National Academy of Sciences

Ämne

  • Medical Genetics

Status

Published

Forskningsgrupp

  • The genetics of soft tissue tumors

ISBN/ISSN/Övrigt

  • ISSN: 1091-6490